Risk factors for developing a second upper aerodigestive cancer after radiotherapy with or without chemotherapy in patients with head-and-neck cancers: An exploratory outcomes analysis-Reference-Cited by-同舟云学术

Risk factors for developing a second upper aerodigestive cancer after radiotherapy with or without chemotherapy in patients with head-and-neck cancers: An exploratory outcomes analysis

Published:2005-07 Issue:3 Volume:62 Page:684-689
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Taussky Daniel,Rufibach Kaspar,Huguenin Pia,Allal Abdelkarim S.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference34 articles.

1. Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head-and-neck squamous cell carcinomas;Fu;Int J Radiat Oncol Biol Phys,2000

2. Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer;Staar;Int J Radiat Oncol Biol Phys,2001

3. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer;Brizel;N Engl J Med,1998

4. Second malignant tumors in head and neck squamous cell carcinoma;Lippman;Int J Radiat Oncol Biol Phys,1989

5. Second primary cancers in patients with laryngeal cancer;Gao;Int J Radiat Oncol Biol Phys,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second infield re‐irradiation with a resulting cumulative equivalent dose (EQD2 max ) of >180 Gy for patients with recurrent head and neck cancer;Head & Neck;2018-12-06

2. Head and Neck Reirradiation;Practical Guides in Radiation Oncology;2017-09-15

3. Reirradiation for second primary or recurrent cancers of the head and neck: Dosimetric and outcome analysis;Head & Neck;2015-08-11

4. Re-irradiation with cetuximab or cisplatin-based chemotherapy for recurrent squamous cell carcinoma of the head and neck;Strahlentherapie und Onkologie;2015-05-25

5. Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors;Annals of Oncology;2012-09